Profil Vitiligo Anak Pasien Rawat Jalan Poliklinik Dermatologi dan Venereologi Rumah Sakit Umum Dr. Moewardi Surakarta

Ivani Ivani, Nur M Rachmat Mulianto, Nurul Hidayati

Sari


ABSTRACT

 

Vitiligo is the most common skin depigmentation condition that occurs in society, around 0.5% -2% of the entire population in the world. Vitiligo occurs as a result of selective and progressive loss of melanocytes in the skin which results in a white macule that is not scaly. To know the profile of vitiligo patients in General Hospital Dr. Moewardi Surakarta in order to achieve proper management. The study was conducted retrospectively by looking at the medical records of vitiligo patients at the Dermatology and Venereology Polyclinic of the Hospital. Moewardi Surakarta for the period January 2019 to December 2022. There were 42 patients with vitiligo in children within 3 years with the highest age range being 13 years. Based on gender characteristics, the number of pediatric vitiligo patients was not much different between men and women, in men there were 17 people (40.48%) and in women there were 25 people (59.52%). With the most lesion areas on the face as many as 25 people. The most widely given therapy was phototherapy with a distribution of 14 people (33%) who received this therapy. 42 vitiligo patients who went to the Dermatology and Venereology Polyclinic at General Hospital Dr. Moewardi Surakarta in the period from January 2019 to December 2022. Vitiligo in children is more common in women with the largest age group being 13 years old. Vitiligo lesions most often appear on the face. Most therapy in patients with phototherapy.

 

Keywords: Vitiligo, Phototherapy, Pigmentation Disorder

 

 

ABSTRAK

 

Vitiligo merupakan kondisi depigmentasi kulit yang paling umum terjadi di masyarakat, sekitar 0,5%-2% dari seluruh populasi di dunia. Vitiligo terjadi akibatnya hilangnya melanosit pada kulit secara selektif dan progresif yang menghasilkan gambaran makula putih yang tidak bersisik. Mengetahui profil pasien vitiligo di RSUD Dr. Moewardi Surakarta agar tercapai penatalaksanaan yang tepat. Penelitian dilakukan secara retrospektif dengan melihat data rekam medik pasien vitiligo di Poliklinik Dermatologi dan Venereologi RSUD Dr. Moewardi Surakarta periode Januari 2019 - Desember 2022. Pasien vitiligo pada anak dalam kurun waktu 3 tahun didapatkan 42 orang dengan rentang usia terbanyak 13 tahun. Berdasarkan karakteristik jenis kelamin, jumlah pasien vitiligo anak tidak jauh berbeda antara laki-laki dan perempuan, pada laki-laki sebanyak 17 orang (40.48%) dan pada perempuan sebanyak 25 orang (59.52%). Regio lesi terbanyak pada wajah sebanyak 25 orang. Pemberian terapi yang paling banyak diberikan adalah fototerapi dengan distribusi 14 orang (33%) yang menerima terapi ini. 42 pasien vitiligo yang berobat ke Poliklinik Dermatologi dan Venereologi RSUD Dr. Moewardi Surakarta dalam rentang waktu Januari 2019 hingga Desember 2022. Vitiligo pada anak lebih sering terjadi pada wanita dengan kelompok usia terbanyak adalah 13 tahun. Lesi vitiligo yang paling sering muncul di daerah wajah. Terapi terbanyak pada pasien dengan pemberian fototerapi.

 

Kata Kunci: Vitiligo, Fototerapi, Kelainan Pigmentasi


Teks Lengkap:

Download Artikel

Referensi


Abdelmaksoud, A., Dave, D. D., Lotti, T., & Vestita, M. (2019). Topical Methotrexate 1% Gel For Treatment Of Vitiligo: A Case Report And Review Of The Literature. Dermatologic Therapy, 32(5), E13013.

Amelinda, N., Ellistasari, E. Y., & Julianto, I. (2022). Modalitas Terapi Vitiligo Pada Anak. Medicinus, 35(3), 37–59.

Ballona, R. (2005). Soft Steroids’o Corticoides Suaves En Dermatología Pediátrica. Dermatol Pediatr Lat, 3, 150–157.

Bertolani, Mariabeatrice, Et Al. (2021). Vitiligo: What’s Old, What’s New. Dermatology Reports 13.2.

Coskun, B., Saral, Y., & Turgut, D. (2005). Topical 0.05% Clobetasol Propionate Versus 1% Pimecrolimus Ointment In Vitiligo. European Journal Of Dermatology, 15(2), 88–91.

El‐Husseiny, R., Abd‐Elhaleem, A., Salah El‐Din, W., & Abdallah, M. (2021). Childhood Vitiligo In Egypt: Clinico‐Epidemiologic Profile Of 483 Patients. Journal Of Cosmetic Dermatology, 20(1), 237–242.

Ezzedine, K., Et Al. (2022). Revised Classification/Nomenclature Of Vitiligo And Related Issues: The Vitiligo Global Issues Consensus Conference. Pigment Cell & Melanoma Research 25.3.

Farajzadeh, S., Khalili, M., Mirmohammadkhani, M., Paknazar, F., Rastegarnasab, F., & Abtahi-Naeini, B. (2023). Global Clinicoepidemiological Pattern Of Childhood Vitiligo: A Systematic Review And Meta-Analysis. Bmj Paediatrics Open, 7(1).

Felsten, L. M., Alikhan, A., & Petronic-Rosic, V. (2011). Vitiligo: A Comprehensive Overview: Part Ii: Treatment Options And Approach To Treatment. Journal Of The American Academy Of Dermatology, 65(3), 493–514.

Gan, E. Y., Cario-André, M., Pain, C., Goussot, J.-F., Taïeb, A., Seneschal, J., & Ezzedine, K. (2016). Follicular Vitiligo: A Report Of 8 Cases. Journal Of The American Academy Of Dermatology, 74(6), 1178–1184.

Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri‐Sole, I., Whitton, M. E., Watts, M. J., Anstey, A. V, Ingham, J., & Young, K. (2008). Guideline For The Diagnosis And Management Of Vitiligo. British Journal Of Dermatology, 159(5), 1051–1076.

Gianfaldoni, Serena, Et Al. (2018). Vitiligo In Children: A Better Understanding Of The Disease. Open Access Macedonian Journal Of Medical Sciences 6.1.

Gianfaldoni, S., Wollina, U., Tchernev, G., Lotti, J., França, K., & Lotti, T. (2018). Vitiligo In Children: A Review Of Conventional Treatments. Open Access Macedonian Journal Of Medical Sciences, 6(1), 213.

Hann, S. K., & Lee, H. J. (1996). Segmental Vitiligo: Clinical Findings In 208 Patients. Journal Of The American Academy Of Dermatology, 35(5), 671–674.

Hojman, L., Cabrera, R., Karsulovic, C., Tempio, F., Perez, C., & López, M. (2021). The Role Of Cxcl10 And Il-18 As Markers Of Repigmentation Response In Nonsegmental Vitiligo Treated With Narrowband Uvb Phototherapy: A Prospective Cohort Study. Journal Of Investigative Dermatology, 141(7), 1833–1836.

Joge Rr, Kathane Pu, J. S. (2022). Vitiligo: A Narrative Review Article.

Komen, L., Da Graça, V., Wolkerstorfer, A., De Rie, M. A., Terwee, C. B., & Van Der Veen, J. P. W. (2015). Vitiligo Area Scoring Index And Vitiligo European Task Force Assessment: Reliable And Responsive Instruments To Measure The Degree Of Depigmentation In Vitiligo. British Journal Of Dermatology, 172(2), 437–443.

Kwon, H. B., Choi, Y., Kim, H. J., & Lee, A.-Y. (2013). The Therapeutic Effects Of A Topical Tretinoin And Corticosteroid Combination For Vitiligo: A Placebo-Controlled, Paired-Comparison, Left-Right Study. J Drugs Dermatol, 12(4), E63-7.

Lee, Young-Bok, And H.-S. K. (2021). Height And Risk Of Vitiligo: A Nationwide Cohort Study. Journal Of Clinical Medicine.

Lepe, V., Moncada, B., Castanedo-Cazares, J. P., Torres-Alvarez, M. B., Ortiz, C. A., & Torres-Rubalcava, A. B. (2003). A Double-Blind Randomized Trial Of 0.1% Tacrolimus Vs 0.05% Clobetasol For The Treatment Of Childhood Vitiligo. Archives Of Dermatology, 139(5), 581–585.

Lotti, T., Agarwal, K., Podder, I., Satolli, F., Kassir, M., Schwartz, R. A., Wollina, U., Grabbe, S., Navarini, A. A., & Mueller, S. M. (2020). Safety Of The Current Drug Treatments For Vitiligo. Expert Opinion On Drug Safety, 19(4), 499–511.

Mahajan, Vikram K., Et Al. (2019). Clinico-Epidemiological Profile Of Patients With Vitiligo: A Retrospective Study From A Tertiary Care Center Of North India. Indian Dermatology Online Journal 10.1.

Mohammad, T. F., Al-Jamal, M., Hamzavi, I. H., Harris, J. E., Leone, G., Cabrera, R., Lim, H. W., Pandya, A. G., & Esmat, S. M. (2017). The Vitiligo Working Group Recommendations For Narrowband Ultraviolet B Light Phototherapy Treatment Of Vitiligo. Journal Of The American Academy Of Dermatology, 76(5), 879–888.

Nimkar, P., & Wanjari, A. (2022). Vitiligo And The Role Of Newer Therapeutic Modalities. Cureus, 14(11).

Njoo, M. D., Spuls, P. I., Bos, J. D. T Al, Westerhof, W., & Bossuyt, P. M. M. (1998). Nonsurgical Repigmentation Therapies In Vitiligo: Meta-Analysis Of The Literature. Archives Of Dermatology, 134(12), 1532–1540.

Patel, R., Pandya, A. G., Sikirica, V., Gandhi, K., Daniel, S. R., Anastassopoulos, K. P., Yamaguchi, Y., Napatalung, L., Baik, R., & Ezzedine, K. (2023). Prevalence Of Vitiligo Among Children And Adolescents In The United States. Dermatology, 239(2), 227–234.

Picardo, M., & Taïeb, A. (2019). Correction To: Vitiligo. Vitiligo, C1–C11.

Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., Harris, J. E., & Group, V. W. (2017). Current And Emerging Treatments For Vitiligo. Journal Of The American Academy Of Dermatology, 77(1), 17–29.

S., N. (2019). Vitiligo Fokal Pada Anak Yang Diterapi Dengan Target Excimer Light 308 Nm.

Seneschal, Julien, Fanny Morice-Picard, And A. T. (2019). Vitiligo, Associated Disorders And Comorbidities (Autoimmune-Inflammatory Disorders, Immunodeficiencies, Rare Monogenic Diseases). Vitiligo.

Silverberg, N. B. (2010). Update On Childhood Vitiligo. Current Opinion In Pediatrics, 22(4), 445–452.

Taieb, A., Alomar, A., Böhm, M., Dell’anna, M. L., De Pase, A., Eleftheriadou, V., Ezzedine, K., Gauthier, Y., Gawkrodger, D. J., & Jouary, T. (2013). Guidelines For The Management Of Vitiligo: The European Dermatology Forum Consensus. British Journal Of Dermatology, 168(1), 5–19.

Taïeb, A., Picardo, M., & Members, Other V. (2007). The Definition And Assessment Of Vitiligo: A Consensus Report Of The Vitiligo European Task Force. Pigment Cell Research, 20(1), 27–35.

Udompataikul, M., Boonsupthip, P., & Siriwattanagate, R. (2011). Effectiveness Of 0.1% Topical Tacrolimus In Adult And Children Patients With Vitiligo. The Journal Of Dermatology, 38(6), 536–540.

Van Geel, N., De Lille, S., Vandenhaute, S., Gauthier, Y., Mollet, I., Brochez, L., & Lambert, J. (2011). Different Phenotypes Of Segmental Vitiligo Based On A Clinical Observational Study. Journal Of The European Academy Of Dermatology And Venereology, 25(6), 673–678.

Van Geel, N., Lommerts, J., Bekkenk, M., Wolkerstorfer, A., Prinsen, C. A. C., Eleftheriadou, V., Taïeb, A., Picardo, M., Ezzedine, K., & Speeckaert, R. (2016). Development And Validation Of The Vitiligo Extent Score (Ves): An International Collaborative Initiative. Journal Of Investigative Dermatology, 136(5), 978–984.

Van Geel, N., & Speeckaert, R. (2017). Segmental Vitiligo. Dermatologic Clinics, 35(2), 145–150.

Van Geel, N., Speeckaert, R., Taieb, A., Picardo, M., Böhm, M., Gawkrodger, D. J., Schallreuter, K., Bennett, D. C., Van Der Veen, W., & Whitton, M. (2011). Koebner’s Phenomenon In Vitiligo: European Position Paper. Pigment Cell & Melanoma Research, 24(3), 564–573.

Yang Tt, Lee Ch, L. C. (2022). Impact Of Vitiligo On Life Quality Of Patients: Assessment Of Currently Available Tools. Int J Environ Res Public Health.

Zhang, Yuhui, Et Al. (2016). The Prevalence Of Vitiligo: A Meta-Analysis.




DOI: https://doi.org/10.33024/mahesa.v5i8.18918

Refbacks

  • Saat ini tidak ada refbacks.


Publisher: Universitas Malahayati Lampung


Creative Commons License
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License


kostenlose besucherzähler